Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.6 EUR
339.54 M EUR
2.96 B EUR
154.18 M
About HIKMA PHARMACEUTICALS ORD GBP0.10
Sector
CEO
Riad Mishlawi
Headquarters
London
Website
Founded
1978
ISIN
GB00B0LCW083
FIGI
BBG000KRDHB3
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
Is this Hikma's cue for a break out?Will Hikma break out after a 5 year H&S pattern,
now that it's making progress in the Covid-19 vaccine business?
Hikma Pharmaceuticals - Injecting some bullish momentum.Buy Hikma Pharmaceuticals (HIK.L)
Hikma Pharmaceuticals PLC develops, manufactures, and markets pharmaceutical products. The Company offers branded and non-branded generic and in-licensed pharmaceutical products. Hikma Pharmaceuticals serves customers worldwide.
Market Cap: £4.79Billion
The lo
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of H5P is 26.2 EUR — it has increased by 0.76% in the past 24 hours. Watch HIKMA PHARMACEUTIC.LS-,10 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HIKMA PHARMACEUTIC.LS-,10 stocks are traded under the ticker H5P.
H5P stock has fallen by −5.04% compared to the previous week, the last month showed zero change in price, over the last year HIKMA PHARMACEUTIC.LS-,10 has showed a 14.91% increase.
We've gathered analysts' opinions on HIKMA PHARMACEUTIC.LS-,10 future price: according to them, H5P price has a max estimate of 37.54 EUR and a min estimate of 24.22 EUR. Watch H5P chart and read a more detailed HIKMA PHARMACEUTIC.LS-,10 stock forecast: see what analysts think of HIKMA PHARMACEUTIC.LS-,10 and suggest that you do with its stocks.
H5P stock is 0.76% volatile and has beta coefficient of 1.13. Track HIKMA PHARMACEUTIC.LS-,10 stock price on the chart and check out the list of the most volatile stocks — is HIKMA PHARMACEUTIC.LS-,10 there?
Today HIKMA PHARMACEUTIC.LS-,10 has the market capitalization of 5.87 B, it has decreased by −0.12% over the last week.
Yes, you can track HIKMA PHARMACEUTIC.LS-,10 financials in yearly and quarterly reports right on TradingView.
HIKMA PHARMACEUTIC.LS-,10 is going to release the next earnings report on Aug 8, 2025. Keep track of upcoming events with our Earnings Calendar.
H5P net income for the last half-year is 124.52 M EUR, while the previous report showed 210.91 M EUR of net income which accounts for −40.96% change. Track more HIKMA PHARMACEUTIC.LS-,10 financial stats to get the full picture.
HIKMA PHARMACEUTIC.LS-,10 dividend yield was 3.16% in 2024, and payout ratio reached 49.64%. The year before the numbers were 3.17% and 81.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIKMA PHARMACEUTIC.LS-,10 EBITDA is 730.84 M EUR, and current EBITDA margin is 24.85%. See more stats in HIKMA PHARMACEUTIC.LS-,10 financial statements.
Like other stocks, H5P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIKMA PHARMACEUTIC.LS-,10 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIKMA PHARMACEUTIC.LS-,10 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIKMA PHARMACEUTIC.LS-,10 stock shows the buy signal. See more of HIKMA PHARMACEUTIC.LS-,10 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.